Popular search terms:
Search Results
15 results found-
CSL Behring is a global biotech company leading the way to deliver innovative therapies for rare and serious diseases.
https://www.cslbehring.com.au/our-company -
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com.au/products -
August 2023 Silver sponsorship of the 21st Conference on Haemophilia, VWD and Rare Bleeding Disorders.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/transparency-reports/csl-behring-third-party-meeting-and-symposia-sponsorship-report-may-2023-to-oct-2023.pdf -
Support was provided to adapt and re-purpose content from a range of sources to provide education and peer support resources for haemophilia communities Haemophilia Foundation Australia across Australia.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/transparency-reports/csl-behring-2022-health-consumer-organisation-support-pdf.pdf -
CSL Behring Marks World Haemophilia Day by Shipping Bleeding Disorders Medicines to the World Federation of Haemophilia
https://www.cslbehring.com.au/news/2018/life-saving-medicines-donated-for-patients-in-the-developing-world -
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/community-grants-pdfs/2023-csl-behring-broadmeadows-community-grant-information-pack.pdf -
Support was provided for the HFA Youth Lead Haemophilia Foundation Australia Connect program which includes education sessions and a social activity aimed at engaging youth.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/transparency-reports/csl-behring-2021-health-consumer-organisation-support-pdf.pdf -
Novel real world evidence for AFSTYLA® and IDELVION® to be highlighted
https://www.cslbehring.com.au/news/2019/20190701-csl-behring-presents-real-world-evidence-findings-at-isth-2019